The venBio team. Front row, L-R: Aaron Royston, Corey Goodman, Richard Gaster; Back row, L-R: Yvonne Yamanaka, Robert Adelman

Corey Good­man's ven­Bio clos­es lat­est VC fund — this time to the tune of $550M — with a dozen or more in­vest­ments on deck

Some of the high­est-pro­file VCs on the West Coast have cob­bled to­geth­er an­oth­er im­pres­sive fund, one that has them more than halfway to a bil­lion dol­lars.

The San Fran­cis­co-based ven­Bio has closed its fourth life sci­ences fund at about $550 mil­lion, the firm an­nounced Thurs­day morn­ing, led by man­ag­ing part­ners Corey Good­man, Robert Adel­man, Aaron Roys­ton and Richard Gaster. ven­Bio is look­ing to sup­port be­tween 12 to 15 com­pa­nies with this fund, Good­man said in a state­ment, aim­ing to pro­vide “stronger sup­port for our port­fo­lio com­pa­nies in crossover rounds and at IPO.”

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.